Analogs of galanthamine and lycoramine as modulators of nicotinic receptors
CA 2393301 A1 · Owner: Davis, Bonnie · Inventors: Davis, Bonnie
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Analogs of galanthamine and lycoramine are useful in modulating nicotinic receptors in humans and other animals. Modulation of such receptors is useful in treatment and/or prevention of a number of conditions including treatment of attention disorders, assistance in giving up smoking and in treatment of , Parkinson's disease.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 7, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 7, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 7, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.